Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Arbidol Hydrochloride as known as Arbidol, is an antiviral treatment for influenza infection.
In February 2020, Li Lanjuan, an expert of the National Health Commission of China, proposed using Arbidol (umifenovir) together with darunavir as a potential treatment during the 2019–20 coronavirus outbreak. Chinese experts claim that preliminary tests had shown that arbidol and darunavir could inhibit replication of the virus. However, later studies showed that it did not show any efficacy in treating the Covid-19 disease. However usage by itself as a post-exposure prophylaxis (PEP) of Covid-19 transmission has been demonstrating positive results though further research is still warranted.
Market Analysis and Insights: Global Arbidol Tablets(COVID-19) Market
The global Arbidol Tablets(COVID-19) market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Arbidol Tablets(COVID-19) Scope and Market Size
The global Arbidol Tablets(COVID-19) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Arbidol Tablets(COVID-19) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
50mg
100mg
Segment by Application
Anti Influenza Virus
COVID-19
The Arbidol Tablets(COVID-19) market is analysed and market size information is provided by regions (countries). Segment by Application, the Arbidol Tablets(COVID-19) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
JSC Pharmstandard
Jiangsu Wuzhong Pharmaceutical
CSPC Ouyi Pharmaceutical
Simcere Pharmaceutical
In February 2020, Li Lanjuan, an expert of the National Health Commission of China, proposed using Arbidol (umifenovir) together with darunavir as a potential treatment during the 2019–20 coronavirus outbreak. Chinese experts claim that preliminary tests had shown that arbidol and darunavir could inhibit replication of the virus. However, later studies showed that it did not show any efficacy in treating the Covid-19 disease. However usage by itself as a post-exposure prophylaxis (PEP) of Covid-19 transmission has been demonstrating positive results though further research is still warranted.
Market Analysis and Insights: Global Arbidol Tablets(COVID-19) Market
The global Arbidol Tablets(COVID-19) market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Arbidol Tablets(COVID-19) Scope and Market Size
The global Arbidol Tablets(COVID-19) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Arbidol Tablets(COVID-19) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
50mg
100mg
Segment by Application
Anti Influenza Virus
COVID-19
The Arbidol Tablets(COVID-19) market is analysed and market size information is provided by regions (countries). Segment by Application, the Arbidol Tablets(COVID-19) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
JSC Pharmstandard
Jiangsu Wuzhong Pharmaceutical
CSPC Ouyi Pharmaceutical
Simcere Pharmaceutical
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
